Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 6569 - 6576 of 12094 results

Proposed Regulations Issued Implementing Massachusetts Employer Medical Assistance Contribution (EMAC) Supplemental Contribution
November 20, 2017| Blog| Viewpoint

Company “Branding” and the Benefits of Federal Trademark Registration
November 20, 2017| Article| Viewpoint

CMS Releases CY 2019 Proposed Rule for Medicare Advantage and Part D
November 20, 2017| Blog| Viewpoint

What Ending H-4 Work Permits Means For Cos., Immigrants
November 20, 2017| News

Massachusetts Health Care Update: Senate Bill, Medication Switching, and Opioids
November 20, 2017| Alert| Viewpoint

Baker-Polito Administration Awards $3.7 Million in Grants for Clean Energy Technology
November 17, 2017| Blog| Viewpoint

Federal Circuit Evaluates Import of Factual Statements Made During BPCIA Pre-litigation Patent Dance
November 17, 2017| Blog| Viewpoint

District Court Denies Motion to Stay Pending Supreme Court Decision in Oil States
November 17, 2017| Blog| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts

Mintz On Air: Practical Policies - Investigations Unscripted
August 12, 2025| Podcast|

Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|

Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
